People with high triglycerides may soon have a new treatment option after researchers reported impressive results from a ...
High blood pressure is one of the world’s most common health problems. It often develops without obvious symptoms, but over ...
The global trial, KARDIA-2, involved 663 people with high blood pressure whose condition wasn't being well managed with their standard treatment. In the trial, patients were given an injection of a ...
A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to ...
Treatment for high blood pressure which has long depended on daily pills could soon move to just two injections a year, according to a new review in The Lancet that outlines late-stage therapies now ...
A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to ...
A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood ...
People with type I diabetes have to inject themselves multiple times a day with manufactured insulin to maintain healthy levels of the hormone, as their bodies do not naturally produce enough. The ...